Veru Inc. (NASDAQ:VERU) Given Average Recommendation of “Buy” by Brokerages


Share on StockTwits

Shares of Veru Inc. (NASDAQ:VERU) have earned an average recommendation of “Buy” from the six ratings firms that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $19.25.

Several brokerages have recently weighed in on VERU. Brookline Capital Management lifted their target price on shares of Veru from $13.00 to $17.00 in a report on Monday, December 14th. Zacks Investment Research upgraded shares of Veru from a “sell” rating to a “hold” rating in a research note on Thursday, February 18th. Cantor Fitzgerald raised their price objective on shares of Veru from $6.00 to $15.00 and gave the company an “overweight” rating in a research note on Monday, December 14th. Oppenheimer raised their price objective on shares of Veru from $19.00 to $24.00 in a research note on Thursday, February 11th. Finally, TheStreet cut shares of Veru from a “b-” rating to a “c” rating in a research note on Monday, March 29th.

In other Veru news, CEO Mitchell Shuster Steiner sold 20,000 shares of Veru stock in a transaction dated Friday, February 12th. The shares were sold at an average price of $20.88, for a total transaction of $417,600.00. Following the completion of the transaction, the chief executive officer now owns 7,184,767 shares in the company, valued at $150,017,934.96. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 26.10% of the company’s stock.

Several large investors have recently bought and sold shares of the company. Panagora Asset Management Inc. grew its holdings in Veru by 462.6% in the fourth quarter. Panagora Asset Management Inc. now owns 3,308 shares of the company’s stock valued at $29,000 after purchasing an additional 2,720 shares during the period. Virtu Financial LLC purchased a new stake in Veru in the third quarter valued at approximately $48,000. Nisa Investment Advisors LLC purchased a new stake in Veru in the fourth quarter valued at approximately $69,000. Advisory Services Network LLC grew its holdings in Veru by 10.3% in the fourth quarter. Advisory Services Network LLC now owns 8,000 shares of the company’s stock valued at $69,000 after purchasing an additional 750 shares during the period. Finally, ProShare Advisors LLC purchased a new stake in Veru in the fourth quarter valued at approximately $102,000. 23.32% of the stock is owned by institutional investors and hedge funds.

Shares of NASDAQ:VERU traded up $0.25 during midday trading on Friday, hitting $10.52. The stock had a trading volume of 30,519 shares, compared to its average volume of 4,057,851. The company has a market capitalization of $756.51 million, a PE ratio of -37.78 and a beta of 0.71. The stock has a 50 day moving average price of $13.65 and a two-hundred day moving average price of $8.06. Veru has a 1 year low of $2.30 and a 1 year high of $24.57.

Veru (NASDAQ:VERU) last issued its earnings results on Wednesday, February 10th. The company reported ($0.02) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.04) by $0.02. The business had revenue of $14.62 million for the quarter, compared to the consensus estimate of $10.63 million. Veru had a negative net margin of 44.55% and a negative return on equity of 23.72%. Equities analysts forecast that Veru will post -0.24 earnings per share for the current fiscal year.

About Veru

Veru Inc, an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N.

Read More: How big is the FinTech market?

Receive News & Ratings for Veru Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veru and related companies with MarketBeat.com's FREE daily email newsletter.